Cerba Research

Cerba Research initiated custom kit building and distribution for an infectious disease study, during the COVID-19 pandemic, in 10 days. A typical timeline is 8 weeks.

For immuno-oncology trials, partner with a global central lab that can generate early insights to optimize your protocol and ramp up to commercial scale while preserving budgets and timelines.

Cerba Research initiated custom kit building and distribution for an infectious disease study, during the COVID-19 pandemic, in 10 days. A typical timeline is 8 weeks.

For immuno-oncology trials, partner with a global central lab that can generate early insights to optimize your protocol and ramp up to commercial scale while preserving budgets and timelines.